Press Release Archive - 2016

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

07 Jan 2016

Antares Pharma to Present at the 34th Annual J.P. Morgan Healthcare Conference
READ  

26 Jan 2016

Antares Pharma Announces CEO Transition
READ  

01 Mar 2016

Antares Pharma to Host Fourth Quarter and Full Year 2015 Operating and Financial Results Call
READ  

08 Mar 2016

Antares Pharma Reports Fourth Quarter and Full Year 2015 Financial and Operating Results
READ  

16 Mar 2016

Antares Announces Completion of the 52 week Quickshot Phase 3 Study in Testosterone Deficient Men
READ  

29 Mar 2016

Additional dosage strengths of Otrexup Methotrexate Injection approved by the FDA
READ  

05 Apr 2016

Antares Pharma Discloses "Pen 1" Development Project as Teriparatide
READ  

25 Apr 2016

Otrexup.com website awarded a Bronze Horizon Interactive Award
READ  

27 Apr 2016

Antares Pharma to Present at the Deutsche Bank Securities,INC. 41st Annual Healthcare Conference
READ  

02 May 2016

Antares Pharma to Host First Quarter Operating and Financial Results Conference Call
READ  

09 May 2016

Antares Pharma Reports First Quarter 2016 Financial and Operating Results
READ  

24 May 2016

Antares Pharma will be attending the BIO International Convention June 6-9 in San Francisco. We look forward to meeting with you at our exhibition booth #5778!
READ  

01 Jun 2016

Antares Pharma Announces Update to Quickshot Testosterone Program
READ  

23 Jun 2016

Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product
READ  

27 Jun 2016

TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States
READ  

02 Aug 2016

Antares Pharma to Report Second Quarter Financial and Operating Results and Host Webcast and Conference Call
READ  

09 Aug 2016

Antares Pharma Reports Second Quarter 2016 Operating And Financial Results
READ  

20 Sep 2016

Antares Pharma to Present at the Ladenberg Thalmann 2016 Healthcare Conference
READ  

22 Sep 2016

Antares Pharma Announces Completion of the Quickshot Testosterone Clinical Program
READ  

28 Oct 2016

ANTARES PHARMA ANNOUNCES MULTIPLE PRESENTATIONS AT THE SEXUAL MEDICINE SOCIETY SCIENTIFIC ANNUAL MEETING
READ  

01 Nov 2016

ANTARES PHARMA APPOINTS FRED M. POWELL, SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
READ  

02 Nov 2016

Antares Pharma Announces Presentations at the Sexual Medicine Society Scientific Annual Meeting
READ  

03 Nov 2016

Antares Pharma to Report Third Quarter Financial and Operating Results and Host Webcast and Conference Call
READ  

09 Nov 2016

ANTARES PHARMA REPORTS THIRD QUARTER 2016 FINANCIAL AND OPERATING RESULTS
READ  

10 Nov 2016

Antares Pharma to Present at the Jefferies 2016 Global Healthcare Conference
READ  

23 Nov 2016

Antares Pharma to Present at the 28th Annual Piper Jaffray Healthcare Conference
READ  

21 Dec 2016

Antares Pharma Announces Submission of New Drug Application for Quickshot Testosterone
READ  

19 Dec 2016

ANTARES PHARMA ANNOUNCES THE SUCCESSFUL COMPLETION OF TEVA’S DECENTRALIZED PROCEDURE FOR TERIPARATIDE INJECTION IN EUROPE
READ